Career history of Christopher Bebbington
Former positions of Christopher Bebbington
| Companies | Position | Start | End |
|---|---|---|---|
| ALLAKOS INC. | Director/Board Member | 2011-12-31 | - |
| Chief Executive Officer | 2011-12-31 | - | |
| Chief Tech/Sci/R&D Officer | - | 2018-05-31 | |
| Founder | 2011-12-31 | 2018-05-31 | |
| President | 2011-12-31 | - | |
| HUMANIGEN, INC. | Chief Tech/Sci/R&D Officer | - | - |
Celscia Therapeutics, Inc.
 Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celscia Therapeutics, Inc. is a company that researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases. The company is based in South San Francisco, CA. The company was founded by Geoffrey Thomas Yarranton, Christopher Bebbington. Celscia Therapeutics was acquired by Humanigen, Inc. on January 12, 2004. | Founder | - | - |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Chief Tech/Sci/R&D Officer | 2012-12-23 | - |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Corporate Officer/Principal | - | - |
Celltech Ltd.
 Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Corporate Officer/Principal | - | - |
Training of Christopher Bebbington
| University of Oxford | Doctorate Degree |
Statistics
International
| United States | 6 |
| United Kingdom | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 5 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ALLAKOS INC. | Health Technology |
| HUMANIGEN, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Celltech Ltd.
Celltech Ltd. Miscellaneous Commercial ServicesCommercial Services Celltech Ltd. provides research and development on natural science and engineering. The company was founded in 1999 and is headquartered in Slough, GB. | Commercial Services |
Coulter Pharmaceuticals, Inc.
Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 1995, Coulter Pharmaceutical is engaged in the development of novel drugs and therapies for the treatment of people with cancer and autoimmune diseases. Currently under development is a family of therapeutics based upon two drug discovery platforms: therapeutic antibodies and targeted oncologics. | Health Technology |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Celscia Therapeutics, Inc.
Celscia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Celscia Therapeutics, Inc. is a company that researches and develops antibody therapeutics for the treatment of cancer and inflammatory/autoimmune diseases. The company is based in South San Francisco, CA. The company was founded by Geoffrey Thomas Yarranton, Christopher Bebbington. Celscia Therapeutics was acquired by Humanigen, Inc. on January 12, 2004. | Commercial Services |
